Enara Bio Competitors and Similar CompaniesClear all

Enara Bio's competitors and similar companies include ImmunoGen, Aeglea and Odyssey Therapeutics.

	Enara Bio Enara Bio (formerly known as Ervaxx) is a biotech company specializing in the use of Dark Antigens to deliver vaccines and other immunotherapies for treating and preventing cancer.	ImmunoGen ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients.	Aeglea Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics.	Odyssey Therapeutics Odyssey Therapeutics is a company that develops precision immunomodulators and oncology medicines.
Founding Date	Founding Date 2016	Founding Date 1981	Founding Date 2013	Founding Date 2021
Type	Type Private	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development oncology	Tags Healthcare biotech drug development oncology	Tags Healthcare biotech drug development oncology	Tags Healthcare biotech drug development oncology
Locations	Locations Oxford, GB HQ London, GB London, GB Oxford, GB	Locations Waltham, US HQ	Locations Austin, US HQ	Locations Boston, US HQ Frankfurt Am Main, DE Ann Arbor, US San Diego, US
Employees	Employees 622% increase	Employees 277161% increase	Employees 65117% increase	Employees 1481% decrease
Valuation ($)	Valuation ($) N/A	Valuation ($) 8.7 b	Valuation ($) 48.6 m	Valuation ($) N/A
Financial
Net income	Net income N/A	Net income ($222.9m) (FY, 2022)	Net income ($155.2m) (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised $ 17.5m	Total funding raised $ 56m	Total funding raised N/A	Total funding raised $ 386m